Pharmaceutical Technology's In the Lab eNewsletter
A suitable tool for analyzing glycans in biopharmaceutical manufacturing is the growing use of analytical enzymes known as exoglycosidases.
Christopher H. Taron
Advertisement
Christopher H. Taron is scientific director, Protein Expression and Modification Division, at New England Biolabs.
Articles by Christopher H. Taron
Advertisement
Latest Updated Articles
Improvement of Structural Profiling of N-glycans in BiologicsNovember 7th 2018
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Improving Oral Peptide Delivery Through Structural Modifications
2
Using OEE Monitoring to Justify Expenditure on Aging Production Lines
3
Regulatory Roundup—October 2026: FDA Advances Rare Disease Development and Transparency Efforts
4
Potent APIs Amplify Carryover Risk: AAPS PharmSci 360 2026
5